Search All News
Jan Hilgeman is one of the rare long-term survivors of pancreatic cancer, and Columbia researchers are now studying her cells in hopes of developing a potential treatment for others with the disease.
An implantable pump that has the potential to transform brain cancer treatment was found safe and effective in people in a study at Columbia University.
Columbia's Barbara Pro, MD, widely recognized for her expertise in developing novel drug treatments for lymphoma, shares her insights.
High school students from the Herbert Irving Comprehensive Cancer Center's summer science program presented their research findings to Columbia scientists at an Oct. 17 poster session.
- January 25, 2022
Columbia cancer researchers are developing virtual reality technology to visualize and explore cancer tumors and gain new insights.
- January 24, 2022
Barbara Pro, MD, a leader in lymphoma research and care, has been named clinical director of the lymphoma program at Columbia University's Herbert Irving Comprehensive Cancer Center.
- December 17, 2021
Innovation and discovery are at the heart of Herbert Irving Comprehensive Cancer Center's mission to reduce the burden of cancer. Learn more in the HICCC's 2021 annual report.
- December 17, 2021
The new center will build upon the dedicated MDS program at Columbia University, a longstanding program of excellence that has served as a national leader in MDS research.
- December 6, 2021
The latest advance in radiation therapy—using AI to adjust treatments as needed—is now available for select cancer patients at Columbia University Irving Medical Center/NewYork-Presbyterian.
- November 24, 2021
The rate of cervical cancer among women living in neighborhoods with the lowest socioeconomic indices is nearly two times higher than the rate among those who live in areas with the highest indices.
- November 22, 2021
Two new Columbia specialists in stomach cancer treatment and research explain what you should know about one of the world's most common cancers.